 RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2022 GLOBE NEWSWIRE -- BioCryst Pharmaceuticals, Inc. Nasdaq: BCRX today announced that the company will present two abstracts, including one Distinguished Industry Oral Abstract, on oral, once-daily ORLADEYO berotralstat for the prophylactic treatment of hereditary angioedema HAE in patients 12 years and older at the Annual Scientific Meeting of the American College of Allergy, Asthma Immunology ACAAI. The meeting will take place at the Kentucky International Convention Center in Louisville, Kentucky, from November 10-14, 2022. 